skip to Main Content

Study Investigates Molecular Profiling for Patients With Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Treatment decisions could be assisted through molecular profiling, which would allow patients and oncologists to evaluate the biological features of the tumor.

A study recently published in Clinical Cancer Research and conducted at the Memorial Sloan Kettering Cancer Center in New York City investigated molecular profiling and the results that could potentially help clinicians make decisions on treatment for the patient. Read more . . .

Back To Top